Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Clinical Actionability of Measurable Residual Disease (MRD) Assessment in the Management of Patients With Hematologic Malignancies: A Case-Based Monograph CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY Wolf, J., Fonseca, R., Muffly, L. 2020; 18 (3)
View details for Web of Science ID 000619716900001